An extranodal diffuse large B-cell lymphoma that arises from the stomach with the bulk of the mass located in the stomach.
Comprehensive, easy-to-understand information about this condition
How we create this content →The limited documentation surrounding gastric diffuse large B-cell lymphoma can be frustrating. This condition affects a relatively small population, which restricts the ability to conduct extensive clinical studies. Additionally, the absence of identified genetic factors and the lack of systematic documentation of clinical features contribute to the challenges in understanding this disease.
To navigate your care effectively, consider seeking a hematologist or oncologist with expertise in lymphomas, particularly those familiar with gastric diffuse large B-cell lymphoma. While there are currently no specific patient organizations identified for this condition, you can access resources such as the Genetic and Rare Diseases Information Center (GARD) at rarediseases.info.nih.gov for additional support. Participation in clinical trials may also be an option, providing access to novel therapies and contributing to the understanding of this disease.
There are several orphan drugs designated for gastric diffuse large B-cell lymphoma, including axicabtagene ciloleucel, lisocabtagene maraleucel, and rituximab. Additionally, there are 8 active clinical trials currently underway, which may offer potential treatment options. You can explore these trials further at ClinicalTrials.gov using this link: https://clinicaltrials.gov/search?cond=gastric%20diffuse%20large%20B-cell%20lymphoma.
Actionable guidance for navigating care for gastric diffuse large B-cell lymphoma
To navigate your care effectively, consider seeking a hematologist or oncologist with expertise in lymphomas, particularly those familiar with gastric diffuse large B-cell lymphoma. While there are currently no specific patient organizations identified for this condition, you can access resources such as the Genetic and Rare Diseases Information Center (GARD) at rarediseases.info.nih.gov for additional support. Participation in clinical trials may also be an option, providing access to novel therapies and contributing to the understanding of this disease.
Consider asking your healthcare providers these condition-specific questions
Helpful links for rare disease information and support
The limited documentation surrounding gastric diffuse large B-cell lymphoma can be frustrating. This condition affects a relatively small population, which restricts the ability to conduct extensive clinical studies. Additionally, the absence of identified genetic factors and the lack of systematic documentation of clinical features contribute to the challenges in understanding this disease.
To navigate your care effectively, consider seeking a hematologist or oncologist with expertise in lymphomas, particularly those familiar with gastric diffuse large B-cell lymphoma. While there are currently no specific patient organizations identified for this condition, you can access resources such as the Genetic and Rare Diseases Information Center (GARD) at rarediseases.info.nih.gov for additional support. Participation in clinical trials may also be an option, providing access to novel therapies and contributing to the understanding of this disease.
There are several orphan drugs designated for gastric diffuse large B-cell lymphoma, including axicabtagene ciloleucel, lisocabtagene maraleucel, and rituximab. Additionally, there are 8 active clinical trials currently underway, which may offer potential treatment options. You can explore these trials further at ClinicalTrials.gov using this link: https://clinicaltrials.gov/search?cond=gastric%20diffuse%20large%20B-cell%20lymphoma.
Actionable guidance for navigating care for gastric diffuse large B-cell lymphoma
To navigate your care effectively, consider seeking a hematologist or oncologist with expertise in lymphomas, particularly those familiar with gastric diffuse large B-cell lymphoma. While there are currently no specific patient organizations identified for this condition, you can access resources such as the Genetic and Rare Diseases Information Center (GARD) at rarediseases.info.nih.gov for additional support. Participation in clinical trials may also be an option, providing access to novel therapies and contributing to the understanding of this disease.
Consider asking your healthcare providers these condition-specific questions
Helpful links for rare disease information and support
The limited documentation surrounding gastric diffuse large B-cell lymphoma can be frustrating. This condition affects a relatively small population, which restricts the ability to conduct extensive clinical studies. Additionally, the absence of identified genetic factors and the lack of systematic documentation of clinical features contribute to the challenges in understanding this disease.
To navigate your care effectively, consider seeking a hematologist or oncologist with expertise in lymphomas, particularly those familiar with gastric diffuse large B-cell lymphoma. While there are currently no specific patient organizations identified for this condition, you can access resources such as the Genetic and Rare Diseases Information Center (GARD) at rarediseases.info.nih.gov for additional support. Participation in clinical trials may also be an option, providing access to novel therapies and contributing to the understanding of this disease.
There are several orphan drugs designated for gastric diffuse large B-cell lymphoma, including axicabtagene ciloleucel, lisocabtagene maraleucel, and rituximab. Additionally, there are 8 active clinical trials currently underway, which may offer potential treatment options. You can explore these trials further at ClinicalTrials.gov using this link: https://clinicaltrials.gov/search?cond=gastric%20diffuse%20large%20B-cell%20lymphoma.
Actionable guidance for navigating care for gastric diffuse large B-cell lymphoma
To navigate your care effectively, consider seeking a hematologist or oncologist with expertise in lymphomas, particularly those familiar with gastric diffuse large B-cell lymphoma. While there are currently no specific patient organizations identified for this condition, you can access resources such as the Genetic and Rare Diseases Information Center (GARD) at rarediseases.info.nih.gov for additional support. Participation in clinical trials may also be an option, providing access to novel therapies and contributing to the understanding of this disease.
Consider asking your healthcare providers these condition-specific questions
Helpful links for rare disease information and support
Clinical profile data for this condition is not yet available. Phenotype information may still be loading below.
Research studies investigating treatments and therapies for this condition.
Active Trials
Total Trials
Data from ClinicalTrials.gov Jan 30, 2026
Consider asking your healthcare providers these condition-specific questions
AI-Generated Content: This summary was generated using AI. Content has been fact-checked. Always consult with qualified healthcare providers for medical guidance.
Kisho delivers this disease record via API, including phenotypes (HPO), genes, orphan drug designations, screening status, and PAG mapping, with version history and governance.